Abbisko Cayman (STU:8ZD) Other Stockholders Equity : €45.50 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Other Stockholders Equity?

Abbisko Cayman's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €45.50 Mil.

Abbisko Cayman's quarterly Other Stockholders Equity declined from Dec. 2023 (€50.75 Mil) to Jun. 2024 (€47.27 Mil) and declined from Jun. 2024 (€47.27 Mil) to Dec. 2024 (€45.50 Mil).

Abbisko Cayman's annual Other Stockholders Equity increased from Dec. 2022 (€43.80 Mil) to Dec. 2023 (€50.75 Mil) but then declined from Dec. 2023 (€50.75 Mil) to Dec. 2024 (€45.50 Mil).

Abbisko Cayman Other Stockholders Equity Historical Data

The historical data trend for Abbisko Cayman's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Other Stockholders Equity Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

8.04

20.33

43.80

50.75

45.50

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial					43.80	53.81	50.75	47.27	45.50

Abbisko Cayman Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Abbisko Cayman Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbisko Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

02256:Hong Kong 8ZD:Germany

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman Headlines

No Headlines